NSPR
HEALTHCAREInspireMD Inc
$1.16+0.06 (+5.45%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving NSPR Today?
No stock-specific AI insight has been generated for NSPR yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.02$2.93
$1.16
Fundamentals
Market Cap$54M
P/E Ratio—
EPS$-0.70
Dividend Yield—
Dividend / Share—
ROE-1.1%
Profit Margin—
Debt / Equity—
Trading
Volume276K
Avg Volume (10D)—
Shares Outstanding46.9M
NSPR News
21 articles- [Form 4] InspireMD, Inc. Insider Trading ActivityStock Titan·May 9, 2026
- InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare ConferenceYahoo Finance·May 6, 2026
- InspireMD, Inc. Q1 2026 Earnings Call SummaryMoby·May 5, 2026
- InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 4, 2026
- InspireMD (NSPR) Q4 2025 Earnings TranscriptMotley Fool·May 4, 2026
- InspireMD (NSPR) Q2 2025 Earnings TranscriptMotley Fool·May 4, 2026
- InspireMD Reports First Quarter 2026 Financial ResultsYahoo Finance·May 4, 2026
- InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection SystemYahoo Finance·May 1, 2026
- InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery SystemYahoo Finance·May 1, 2026
- InspireMD to Announce First Quarter 2026 Financial ResultsYahoo Finance·Apr 27, 2026
- After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR)Yahoo Finance·Apr 8, 2026
- InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare ConferenceYahoo Finance·Mar 31, 2026
- InspireMD Inc (NSPR) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic AdvancementsYahoo Finance·Mar 18, 2026
- InspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue EstimatesYahoo Finance·Mar 18, 2026
- InspireMD Reports Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Mar 18, 2026
- InspireMD to Announce Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Mar 9, 2026
- NeuroPace, Inc. (NPCE) Reports Q4 Loss, Beats Revenue EstimatesYahoo Finance·Mar 3, 2026
- InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance·Jan 20, 2026
- InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)Yahoo Finance·Jan 12, 2026
- InspireMD (NASDAQ:NSPR) shareholders have endured a 81% loss from investing in the stock five years agoYahoo Finance·Jan 10, 2026
- Is InspireMD (NASDAQ:NSPR) In A Good Position To Invest In Growth?Yahoo Finance·Nov 27, 2025
All 21 articles loaded
Price Data
Open$1.11
Previous Close$1.10
Day High$1.21
Day Low$1.09
52 Week High$2.93
52 Week Low$1.02
52-Week Range
$1.02$2.93
$1.16
Fundamentals
Market Cap$54M
P/E Ratio—
EPS$-0.70
Dividend Yield—
Dividend / Share—
ROE-1.1%
Profit Margin—
Debt / Equity—
Trading
Volume276K
Avg Volume (10D)—
Shares Outstanding46.9M
About InspireMD Inc
InspireMD, Inc., a medical device company, is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular disease in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—